The global medical device landscape is rapidly evolving as connected healthcare technologies, cloud-integrated platforms, and IoMT ecosystems become standard in modern clinical environments. For medical device manufacturers in the Philippines aiming to access the U.S. market, cybersecurity has become a non-negotiable requirement—especially under the FDA’s strengthened 510(k) cybersecurity expectations.
Cyberintelsys supports Philippine manufacturers with end-to-end cybersecurity evaluation, technical testing, and regulatory documentation designed to meet FDA 510(k) cybersecurity requirements with precision and confidence.
Why Cybersecurity Matters for FDA 510(k) Compliance?
The FDA mandates that all connected medical devices demonstrate resilience against cyberattacks that could compromise:
Patient safety
Therapy delivery
Device accuracy
Clinical workflows
Sensitive health data
A single exploited vulnerability in firmware, wireless communication, or cloud integration can alter device behavior and jeopardize care outcomes.
Because of these risks, cybersecurity controls and verification are now a core part of the FDA 510(k) submission process.
What FDA Expects in 510(k) Cybersecurity Submissions?
Manufacturers must provide clear, tested, and validated cybersecurity evidence covering:
Threat modeling
Secure design controls
SBOM documentation
Vulnerability assessment and penetration testing
Patch and update mechanisms
Encryption and access control implementation
Cyber risk management aligned with ISO 14971
Security verification and validation results
Cyberintelsys provides all required assessments, test results, and submission-ready reports tailored for FDA reviewers.
Cyberintelsys 510(k) Cybersecurity Gap Analysis & Assessment Framework
1. Initial Cybersecurity Gap Analysis:
Our team evaluates your device against:
AAMI TIR57 / TIR97
ISO 14971 & IEC 81001-5-1
UL 2900 standards
You receive a detailed gap report outlining missing controls, required upgrades, and prioritized remediation actions.
2. Device Architecture & Design Evaluation:
We review:
Hardware components
Firmware architecture
Communication interfaces
Cloud and mobile application integration
Authentication and access control design
Data flow and encryption mechanisms
This ensures the device aligns with FDA expectations for secure-by-design engineering.
3. Vulnerability Assessment (VA):
Our VA process includes:
Firmware vulnerability scanning
SBOM verification and dependency analysis
Configuration and hardening review
Network and wireless security inspection
API and cloud security analysis
All findings include CVSS scoring and recommended mitigations.
4. Penetration Testing (PT)
We execute targeted exploitation attempts across:
Device hardware and interfaces
IoMT communication channels (Wi-Fi, BLE, Zigbee, NFC)
Firmware and bootloader
Cloud platform and APIs
Mobile companion apps
Web portals
Testing replicates real-world attack paths used by threat actors.
5. Threat Modeling & Cyber Risk Assessment
Using STRIDE and FDA-aligned methodologies, Cyberintelsys identifies:
Possible attack vectors
Exploitable weaknesses
Impact on clinical safety
Required mitigation controls
This analysis forms a critical part of your FDA cyber risk submission.
6. FDA 510(k) Cybersecurity Documentation
Cyberintelsys prepares submission-ready documents, including:
Cybersecurity risk management file
VA/PT testing reports
SBOM and vulnerability management plan
Secure update and patching strategy
Access control and authentication documentation
Security architecture diagrams
Verification & Validation (V&V) evidence
These documents are formatted to match FDA cybersecurity section requirements.
7. Retesting & Compliance Validation
After remediation, we verify that:
All vulnerabilities are fixed
Residual risks are acceptable
Documentation matches updated design
Device security posture meets FDA expectations
This final step ensures readiness before filing your 510(k).
Devices Supported
Cyberintelsys works with all major device categories, including:
1. Diagnostic Devices:
MRI, X-ray, CT, ultrasound, and laboratory analyzers.
2. Therapeutic Devices:
Infusion pumps, ventilators, dialysis systems, insulin delivery devices.
3. IoMT & Remote Monitoring Platforms:
Wearables, telemetry devices, smart sensors.
4. Software & Digital Health Systems:
SaMD, mobile health apps, cloud healthcare platforms, EHR-integrated tools.
Why Philippine Manufacturers Choose Cyberintelsys?
Deep expertise in FDA 510(k) cybersecurity requirements
Strong knowledge of embedded, firmware, IoMT, cloud, and mobile ecosystems
CREST-certified cybersecurity specialists
Clear, structured documentation for faster regulatory approval
Cost-effective support tailored for Philippine medical device companies
End-to-end assessment from design review to V&V documentation
Cyberintelsys simplifies the compliance journey while strengthening the overall security posture of your device.
Conclusion
Cybersecurity is now a critical determinant of FDA 510(k) approval. For Philippine medical device manufacturers entering global markets, comprehensive cybersecurity gap analysis, testing, and documentation are essential.
Cyberintelsys delivers complete 510(k) cybersecurity readiness—covering regulatory gap analysis, technical testing, SBOM review, threat modeling, secure design evaluation, and submission-ready documentation. With our support, your medical device is better protected, compliant, and fully prepared for FDA clearance.